A3 Clinical Trials
Seminar Room 2, Newton Institute Gatehouse
Stephen Senn will discuss lost opportunities for the application of design theory in
drug development giving examples where theoreticians have not aid sufficient
attention to design realities but also cases where practitioners have missed applying
useful theory. Michael Krams will cover the 'hot topic' of adaptive design using
various case studies, illustrating these from many perspectives, including those of
investigators, researchers, patients and data monitoring committees.
The objective of this session will be to illustrate areas in which design theory can
make a real contribution to drug development provided that genuine collaboration
with practitioners is sought.